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ABSTRACT
LEOPARD syndrome (LS) is a rare hereditary disorder in Asian countries. This syndrome consists of multiple systemic ab-
normalities. In particular, characteristic cardiovascular effects in LS may include variable clinical manifestations from benign 
to life-threatening courses. The cardiac effects of this syndrome consist of left ventricular hypertrophy (LVH), pulmonary ste-
nosis (PS), coronary artery dilatation and electrocardiogram(ECG) abnormalities. Since there are few LS patients who have 
undergone a complete cardiovascular evaluation, the nature and clinical prognosis of cardiovascular abnormalities in this syn-
drome remain uncertain. Also, there have been few reports on therapeutic strategies for cardiovascular abnormalities in LS. 
Here we describe a case of LS who presented with multiple cardiovascular problems and underwent successful surgical and 
medical treatment. (Korean Circ J 2010;40:339-342)
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Introduction
LEOPARD syndrome (LS) is a rare, multi-systemic, con-
genital disorder. This disorder is known to be inherited in an 
autosomal dominant pattern. A missense mutation in the 
protein-tyrosine phosphatase nonreceptor type 11 (PTPN11) 
gene is the key mutation responsible for the development of 
LS.
1)2) The diagnosis of this syndrome is based on multiple 
lentigines with ≥3 cardinal features.
3) When lentigines are ab-
sent, ≥3 other features in patients with LS are diagnostic. In 
children or young patients without lentigines, LS is diagnosed 
in the presence of ≥3 of the following criteria: cardiovascular 
abnormalities, café au lait spots, sensorineural deafness, hyp-
tonia or delayed motor development and distinct facial ab-
normalities such as hypertelorism, downslanting palpebral 
fissure, palpebral ptosis and ear abnormalities.
2)
The characteristic cardiovascular abnormalities associated 
with LS are left ventricular hypertrophy (LVH), pulmonary 
stenosis (PS), electrocardiographic (ECG) abnormalities and 
coronary artery dilatation.
4) All of these abnormalities may 
progress with age or be detected later in life than other clini-
cal findings.
5) Therapeutic plans for cardiovascular abnormal-
ities in LS should be aimed at adverse cardiac events second-
ary to valvular heart disease or LVH. Here we demonstrate a 
case of LS who had multiple cardiovascular problems and re-
ceived successful surgical valve replacement and medical tr-
eatment.
Case
A 47-year-old Korean man presented with palpitations and 
exertional dyspnea (New York Heart Association class III). 
On physical examination, he was of notably short stature. He 
displayed ocular hypertelorism on his face (Fig. 1A) and der-
mographic lentiginous skin lesions distributed on his right 
arm and chest (Fig. 1B and C). His height was 134 cm and 
weight was 36 kg. In cardiac auscultation, a grade 3/6 systolic 
ejection murmur was heard at the left second intercostal space. 
He had no family members with whom we could make con-340   Management of LEOPARD Syndrome
tact. He showed no communication disability or signs of men-
tal retardation.
An initial 12 lead ECG revealed a sustained ventricular 
tachycardia (VT) that originated from the apical inferoseptal 
LV wall (Fig. 1D). Blood pressure and heart rate were 90/60 
mmHg and 185/min, respectively. He was immediately given 
150 mg of intravenous amiodarone for 10 minutes and the 
ECG recovered from VT and demonstrated normal sinus rhy-
thm with right bundle branch block pattern (Fig. 1E). An ini-
tial echocardiogram showed diffuse LVH (Fig. 2A). Contin-
uous wave (CW) Doppler revealed a severe form of PS {maxi-
mal velocity: 4.2 m/s, pulmonic valve (PV) peak pressure gra-
dient: 69.6 mmHg} (Fig. 2B). In addition, the measurement 
of right ventricular (RV) systolic pressure revealed severe PS 
(maximal velocity: 4.1 m/s, right atrial pressure: 15 mmHg, 
RV systolic pressure: 81.9 mmHg) (Fig. 2C).
He had ≥3 characteristic features of LS consistent with di-
agnostic criteria for LS. We planned to perform PV replace-
ment surgery to relieve heart failure symptoms. Because he 
responded well to amiodarone, we maintained him on oral 
amiodarone therapy to suppress the VT. On the evaluation of 
coronary artery abnormalities by cardiac 64-slice multide-
tector computed tomography (64-MDCT, Aquilion 64; Toshi-
ba Medical Systems, Tokyo, Japan), the coronary arteries were 
normal but the pulmonary trunk was significantly dilated 
(Fig. 2D). 
We performed surgical PV replacement with infundibulec-
tomy and transannular RV outflow tract widening. The native 
PV was replaced by use of a 23 mm Carpentier-Edwards peri-
cardial prosthetic valve. After successful PV replacement, clin-
ical symptoms were significantly improved without any post-
operative complications. Nine months later, follow-up echo-
cardiography showed a well-functioning prosthetic PV (ma-
ximal velocity: 1.6 m/s, PV peak pressure gradient: 10.1 mmHg) 
(Fig. 3A) and improved PS (maximal velocity: 2.65 m/s, right 
atrial pressure: 10 mmHg, RV systolic pressure: 38.6 mmHg) 
(Fig. 3B). We did a follow-up cardiac 64-MDCT scan to eval-
uate changes in post-stenotic dilatation of the pulmonary 
trunk after surgery. Pulmonary trunk size had decreased from 
45.4 mm to 37.6 mm after PV replacement (Fig. 3C). There has 
been no recurrence of heart failure symptoms or VT during the 
past 12 months.
Fig. 1. Typical ocular hypertelorism is seen on the patient’s face (A). Lentigines, of large dermographic black-brownish character, are distrib-
uted over his arm, chest (B and C). The initial ECG shows ventricular tachycardia that originated from the apical inferoseptal left ventricular 
wall (D). Follow-up ECG after intravenous amiodarone injection demonstrates normal sinus rhythm with right bundle branch block (E). ECG: 
electrocardiogram.
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Discussion
Cardiac involvement in patients with LS is usually charac-
terized by LVH, PS and ECG abnormalities. As the cardiac 
involvement in LS resembles Noonan syndrome, the differ-
ential diagnosis should be made by careful examination.
6) In 
the largest published study on LS, LVH was shown to be the 
most common cardiac abnormality.
4) Asymmetric LVH is more 
common than apical or concentric hypertrophy. RV hyper-
trophy may also accompany LVH and PS in about 30% of 
patients with LS.
7) Previous studies have reported that the ap-
pearance and degree of LVH occurs concomitantly with the 
first manifestation of multiple lentigenes.
8) 
PS is less frequent than LVH in patients with LS. It can be 
observed in about 40% of reported cases.
5) Valvular or infun-
dibular PS is a common type of PS in patients with LS. Mitral 
or aortic valvular anomalies may occur sporadically as well. 
ECG abnormalities occur in about 75% of LS patients, in-
cluding LVH or biventricular hypertrophy in 46% of them, 
often in association with q waves, a prolonged QTc, and repo-
larization abnormalities.
4) Arrhythmogenic properties of LVH 
may induce life-threatening VT or other tachyarrhythmic 
events in this syndrome. However, the incidence of sudden 
cardiac death due to ventricular arrhythmia is unclear. 
Coronary artery dilatation or aneurysm can be detected in-
cidentally by coronary angiography or cardiac 64-MDCT. How-
ever, the clinical significance of coronary artery abnormali-
ties needs further investigation.
Overall prognosis for LS is primarily determined by the 
presence and severity of cardiac abnormalities. Therefore, pro-
per surgical or medical management should be emphasized. 
Long-term prognosis of LS seems benign with only mild car-
diac involvement. As in our case, the patient with LVH and 
PS may present with significant symptoms and arrhythmic 
events during follow-up. Several studies suggest that patho-
logic and clinical findings may be similar in familial hypertro-
phic cardiomyopathy and LVH associated with LS. Because 
our patient showed a favorable response to oral amiodarone 
therapy, we did not insert an implantable cardioverter defi-
brillator (ICD) which is recommended for patients with fam-
ilial hypertrophic cardiomyopathy. Also, the patient showed 
no premature ventricular complex or non-sustained VT on 
Holter monitoring during oral amiodarone maintenance. If 
LVH or arrhythmic events are aggravated on follow-up moni-
toring, we would consider ICD implantation for primary pre-
vention against sudden death, even if the patient were asymp-
tomatic.
We experienced a case of LS who had multiple cardiovas-
cular abnormalities including PS and LVH, and received suc-
cessful surgical and medical treatment. Our clinical report 
Fig. 2. Initial echocardiography showing diffuse left ventricular hypertrophy (A). Initial pulmonic valve peak pressure gradient and right 
ventricular systolic pressure by use of continuous wave Doppler are, respectively, 69.6 mmHg (B) and 81.9 mmHg (C). Cardiac 64-MDCT 
demonstrating post-stenotic dilatation of the pulmonary trunk (arrows) (D) with a maximal diameter of 45.4 mm.
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suggests that complete cardiovascular screening in patients 
with LS may be essential and beneficial to determine ideal 
medical and surgical therapeutic strategies. 
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Fig. 3. Follow-up pulmonic valve peak pressure gradient and right ventricular systolic pressure by use of continuous wave Doppler are, re-
spectively, 10.1 mmHg (A) and 38.1 mmHg (B). Follow-up Cardiac 64-MDCT demonstrating a marked reduction in post-stenotic dilatation of 
the pulmonary trunk, with a maximal diameter of 37.6 mm (arrows) (C).
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